Organism 211453 -

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.

Organism Details

PropertyValue
Family
Genus
Species
Species authority
Subspecies
Subspecies authority
Comment
CitationGNERRE,C: THULL,U: GAILLARD,P: CARRUPT,PA: TESTA,B: FERNANDES,E: SILVA,F: PINTO,M: PINTO,MMM: WOLFENDER,JL: HOSTETTMANN,K: CRUCIANI,G:. (2001). NATURAL AND SYNTHETIC XANTHONES AS MONOAMINE OXIDASE INHIBITORS: BIOLOGICAL ASSAY AND 3D-QSAR.. 84(3)

Experiments

Filters
Worktypes (7)
38
17
17
17
17
16
5
No match
Pharmacology (3)
19
19
17
No match
Compounds (19)
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
No match
55 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
754330
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE
754331
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE
754332
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,1-3-DIHYDROXY-2-METHYL:
754333
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,1-3-DIHYDROXY-2-METHYL:
754334
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,2-3-4-TRIMETHOXY:
754335
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,2-3-4-TRIMETHOXY:
754336
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,2-3-4-TRIMETHOXY:
754337
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,3-HYDROXY-4-METHOXY:
754338
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,3-HYDROXY-4-METHOXY:
754339
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,3-HYDROXY-4-METHOXY:
754340
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,4-HYDROXY-3-METHOXY:
754341
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,4-HYDROXY-3-METHOXY:
754342
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,4-HYDROXY-3-METHOXY:
754343
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,3-4-DIMETHOXY:
754344
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,3-4-DIMETHOXY:
754345
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,3-4-DIMETHOXY:
754346
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,3-5-DIMETHOXY:
754347
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,3-5-DIMETHOXY:
754348
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,3-5-DIMETHOXY:
754349
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,1-3-DIMETHOXY:
754350
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,1-3-DIMETHOXY:
754351
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,1-3-DIMETHOXY:
754352
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,1-HYDROXY-3-METHOXY:
754353
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,1-HYDROXY-3-METHOXY:
754354
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,1-HYDROXY-3-METHOXY:
754355
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,3-HYDROXY-5-METHOXY:
754356
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,3-HYDROXY-5-METHOXY:
754357
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,3-HYDROXY-5-METHOXY:
754358
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,3-5-DIHYDROXY:
754359
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,3-5-DIHYDROXY:
754360
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,3-5-DIHYDROXY:
754361
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,4-METHOXY:
754362
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,4-METHOXY:
754363
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,4-METHOXY:
754364
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,4-HYDROXY:
754365
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,4-HYDROXY:
754366
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,4-HYDROXY:
754367
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,7-METHOXY:
754368
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,7-METHOXY:
754369
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,7-METHOXY:
754370
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDCOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,3-HYDROXY:
754371
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,3-HYDROXY:
754372
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,3-HYDROXY:
754373
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,2-METHOXY:
754374
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,2-METHOXY:
754375
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,2-METHOXY:
754376
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,2-HYDROXY:
754377
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,2-HYDROXY:
754378
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,2-HYDROXY:
754379
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,1-METHOXY:
754380
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,1-METHOXY:
754381
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,1-METHOXY:
754382
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDCOMPLETE SYNTHESIS REPORTEDINFRARED SPECTRUM REPORTED FOR
Empty organism
XANTHONE,1-HYDROXY:
754383
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE A)
Empty organism
XANTHONE,1-HYDROXY:
754384
PHARMACOLOGY OF COMPOUND - IN VITRO
MONOAMINE OXIDASE INHIBITION(TYPE B)
Empty organism
XANTHONE,1-HYDROXY:
Show SPARQL Queries (1)